[177Lu]Lu-DOTATATE peptide receptor radionuclide therapy-associated myeloid neoplasms: insights from the WHO pharmacovigilance database

[¹⁷⁷Lu]Lu-DOTATATE peptide receptor radionuclide therapy-associated myeloid neoplasms: insights from the WHO pharmacovigilance database

Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3332-3333. doi: 10.1007/s00259-022-05833-6. Epub 2022 May 6.

Jonathan Vigne^{1

2

3}, Basile Chrétien⁴, Anne-Laure Bignon⁵, Karine Bouhier-Leporrier⁵, Charles Dolladille⁶

¹ Department of Nuclear Medicine, CHU de Caen Normandie, Normandie Université, UNICAEN, Avenue de La Côte de Nacre, CS 30001, 14033 Caen CEDEX 9, Caen, France. vigne-jo@chu-caen.fr.
² Department of Pharmacy, CHU de Caen Normandie, Normandie Université, UNICAEN, 14000, Caen, France. vigne-jo@chu-caen.fr.
³ INSERM U1237, PhIND, Institut Blood and Brain @ Caen-Normandie, Centre Cyceron, Normandie Université, UNICAEN, 14000, Caen, France. vigne-jo@chu-caen.fr.
⁴ Pharmacoepidemiology Unit, Department of Pharmacology, Pharmacovigilance Regional Center, Caen University Hospital, Caen, France.
⁵ Department of Hepato-Gastroenterology and Nutrition, Caen University Hospital, 14000, Caen, France.
⁶ Department of Pharmacology, Caen University Hospital, INSERM U1086 ANTICIPE, Normandie University, UNICAEN, Caen, France.

No abstract available